A global risk-attribution analysis suggests that exposure to Helicobacter pylori may be associated with 22% of colorectal cancer cases worldwide.…
Browsing: Clinical Updates
The FDA has cleared a clinical trial at the University of Colorado Anschutz testing an experimental CAR T-cell therapy in…
A retrospective study of 383 patients undergoing bariatric surgery at UCSF found that prior GLP-1 receptor agonist use was not…
A reanalysis of Sweden’s population-based colorectal cancer screening program suggests that the mortality benefit of fecal occult blood testing (FOBT)…
The 13-year follow-up of the NORDICC randomized trial found that a single screening colonoscopy reduced colorectal cancer incidence but did…
A reanalysis of Sweden’s population-based fecal occult blood test (FOBT) screening program suggests that the mortality benefit of colorectal cancer…
BioNTech is ending a mid-stage trial of its experimental personalized mRNA cancer vaccine, autogene cevumeran, after an independent committee concluded…
Researchers at Nanyang Technological University developed peptide microdroplets that deliver siRNA into T cells and colorectal cancer cells to suppress…
New studies suggest that physical activity may decline rather than increase after starting GLP-1 medications, despite recommendations to exercise to…
Carelon Health Services will add Guardant Health’s Shield blood test to its colorectal cancer screening coverage guidelines effective Nov. 15,…